<![CDATA[CAR-T, Allogene Therapeutics Hits the Nasdaq]]>"Allogene Therapeutics began trading on the Nasdaq Stock Exchange today under the ALLO ticker. The price was at the top of its range, $18 per share. The company plans to raise $288 million with the sale of about 16 million shares".

https://www.biospace.com/article/focused-on-off-the-shelf-car-t-allogene-therapeutics-hits-the-nasdaq-at-18-per-share/

]]>https://dev.proinvestor.com/forum/topic/439902/car-t-allogene-therapeutics-hits-the-nasdaqRSS for NodeFri, 17 Jul 2026 04:29:59 GMTSun, 14 Oct 2018 03:45:07 GMT60